To include your compound in the COVID-19 Resource Center, submit it here.

Jury awards Asahi $547M in suit against Actelion

A jury in a California superior court awarded Asahi Kasei Pharma Corp. (Tokyo, Japan) up to $547 million from Actelion Ltd. (SIX:ATLN) related to Actelion's termination of a deal

Read the full 294 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE